Last updated at 09 Aug 2024 03:34 AM
Director
DIN: 06975385
Naresh Kumar Hasija is currently associated with 2 companies in various capacities such as Director, Individual Subscriber and CEO. They serve as a Director at GLOBIOSAGE PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06975385.Naresh Kumar Hasija is currently involved in 3 different roles. Their most recent position is with REMEDI HEALTHCARE INDIA PRIVATE LIMITED as a Individual Subscriber. The first company Naresh Kumar Hasija was appointed to as a director was GLOBIOSAGE PHARMA PRIVATE LIMITED. Naresh Kumar Hasija is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Naresh Kumar Hasija is currently associated with 2 companies in various capacities such as Director, Individual Subscriber and CEO. They serve as a Director at GLOBIOSAGE PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06975385.Naresh Kumar Hasija is currently involved in 3 different roles. Their most recent position is with REMEDI HEALTHCARE INDIA PRIVATE LIMITED as a Individual Subscriber. The first company Naresh Kumar Hasija was appointed to as a director was GLOBIOSAGE PHARMA PRIVATE LIMITED. Naresh Kumar Hasija is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
2y 2m 1y 1m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| GLOBIOSAGE PHARMA PRIVATE LIMITED | Director | 04-Feb-2015 |
| REMEDI HEALTHCARE INDIA PRIVATE LIMITED | Individual Subscriber | 20-Nov-2023 |
| REMEDI HEALTHCARE INDIA PRIVATE LIMITED | CEO | 01-Dec-2023 |